申请人:GLAXOSMITHKLINE IP DEV LTD
公开号:WO2020225273A1
公开(公告)日:2020-11-12
Disclosed herein are new C-mannoside compounds and compositions and their application as pharmaceuticals for the treatment of human disease. Methods of inhibition of FimH activity in human subjects are also provided for the treatment diseases such as urinary tract infection.
本文披露了新的C-甘露苷化合物和组合物,以及它们作为治疗人类疾病的药物的应用。还提供了用于治疗疾病(如尿路感染)的抑制人体中FimH活性的方法。